Chemomab Therapeutics Ltd. (CMMB) stock
CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.55−0.09 (-5.49%)
Close on Nov 18, 2026Market cap $11.15MP/E 1.1Yield –
Chemomab Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Chemomab Therapeutics's shares outstanding was 640M at Jun 30, 2026. For fiscal 2025 it was 510M, up 42.1% from the year before. The highest annual figure on record is 510M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 510M | +42.1% |
| FY2024 | Dec 31, 2024 | 359M | +52.8% |
| FY2023 | Dec 31, 2023 | 235M | +3.3% |
| FY2022 | Dec 31, 2022 | 228M | +9.7% |
| FY2021 | Dec 31, 2021 | 207M | +51.7% |
| FY2020 | Dec 31, 2020 | 137M | +113332.6% |
| FY2019 | Dec 31, 2019 | 0M | -99.7% |
| FY2018 | Dec 31, 2018 | 44M | +40.0% |
| FY2017 | Dec 31, 2017 | 32M | +66.1% |
| FY2016 | Dec 31, 2016 | 19M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 640M | +189.7% |
| Q2 FY2025 | Jun 30, 2025 | 464M | +105.7% |
| Q2 FY2024 | Jun 30, 2024 | 286M | +25.0% |
| Q2 FY2023 | Jun 30, 2023 | 222M | -2.8% |
| Q1 FY2023 | Mar 31, 2023 | 221M | -3.1% |
| Q4 FY2022 | Dec 31, 2022 | 225M | -7.7% |
| Q3 FY2022 | Sep 30, 2022 | 229M | +0.4% |
| Q2 FY2022 | Jun 30, 2022 | 228M | +5.5% |
| Q1 FY2022 | Mar 31, 2022 | 228M | +45.5% |
| Q4 FY2021 | Dec 31, 2021 | 244M | +69.5% |
| Q3 FY2021 | Sep 30, 2021 | 228M | +63.5% |
| Q2 FY2021 | Jun 30, 2021 | 216M | +66.7% |
| Q1 FY2021 | Mar 31, 2021 | 157M | +20.8% |
| Q4 FY2020 | Dec 31, 2020 | 144M | +10.9% |
| Q3 FY2020 | Sep 30, 2020 | 139M | +7.4% |
| Q2 FY2020 | Jun 30, 2020 | 130M | +40.8% |
| Q1 FY2020 | Mar 31, 2020 | 130M | – |
| Q3 FY2019 | Sep 30, 2019 | 130M | – |
| Q2 FY2019 | Jun 30, 2019 | 130M | – |
| Q1 FY2019 | Mar 31, 2019 | 92M | – |
See a number that looks wrong?